Trial Profile
The Japan Hypertension Evaluation with Angiotensin 2 Antagonist Losartan Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2012
Price :
$35
*
At a glance
- Drugs Losartan (Primary)
- Indications Cardiovascular disorders; Hypertension
- Focus Therapeutic Use
- Acronyms J-HEALTH study
- Sponsors Merck Sharp & Dohme
- 12 Aug 2011 New trial record